Suchergebnisse - "Editorial"

PubPharm (1.351)

1

Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide in patients with chronic hepatitis B : More questions than an answer

enthalten in: Clinical and molecular hepatology | 2024

von Cheng, P. | Yu, M.

CommentOn: Clin Mol Hepatol. 2024 Jan;30(1):49-63. - PMID 37981763

2

A revolutionary oral HBV treatment candidate as innovative therapeutic approach warranting clinical trials

enthalten in: Journal of gastroenterology | 2024

von Matsui, T.

3

Toward hepatitis C virus elimination using artificial intelligence

enthalten in: Clinical and molecular hepatology | 2024

von Hur, M. | Lee, J.

CommentOn: Clin Mol Hepatol. 2024 Jan;30(1):64-79. - PMID 38195113

4

Enhancing off-nucleos(t)ide analogue outcome predictions in chronic hepatitis B with time-varying hepatitis B core-related antigen

enthalten in: Clinical and molecular hepatology | 2024

von Huang, C. | Tseng, T.

CommentOn: Clin Mol Hepatol. 2024 Jan;30(1):98-108. - PMID 38092551

5

Nirmatrelvir and ritonavir

enthalten in: Clinical therapeutics | 2024

von Beninger, P.

6

One - or more - blind spot(s) unveiled in the new definition of decompensated cirrhosis

enthalten in: Journal of hepatology | 2024

von Artru, F. | Reiberger, T.

7

In the era of antiviral trials for MS, the answer lies in the details

enthalten in: Multiple sclerosis and related disorders | 2024

von Drosu, N. | Bjornevik, K. | Bilodeau, P. | +5

8

Management of autoimmune hepatitis induced by hepatitis delta virus

enthalten in: World journal of gastroenterology | 2024

von Gigi, E. | Lagopoulos, V. | Liakos, A.

9

Could Molnupiravir Be the First-Line Alternative Oral Antiviral Agent for COVID-19 Patients at High Risk?

enthalten in: Journal of Korean medical science | 2024

von Lee, J.

10

Unraveling the role of the liver myeloid compartment during hepatitis C virus cure

enthalten in: Journal of hepatology | 2024

von Crouchet, E. | Baumert, T.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[136]